How have SBTX shares performed in 2024?

SkinBioTherapeutics' stock was trading at GBX 15.25 at the beginning of the year. Since then, SBTX stock has decreased by 39.3% and is now trading at GBX 9.25. View the best growth stocks for 2024 here .

How were SkinBioTherapeutics' earnings last quarter?

SkinBioTherapeutics plc (LON:SBTX) released its earnings results on Tuesday, March, 3rd. The company reported ($0.64) earnings per share (EPS) for the quarter.

What other stocks do shareholders of SkinBioTherapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SkinBioTherapeutics investors own include Avacta Group (AVCT) , Inspired (INSE) , OptiBiotix Health (OPTI) , Lb-shell (LBP) , Anglo African Oil & Gas (AAOG) , Big Sofa Technologies Group (BST) , Concepta PLC (CPT.L) (CPT) , Fresnillo (FRES) and Shield Therapeutics (STX) .

How do I buy shares of SkinBioTherapeutics?

Shares of SBTX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:SBTX

SkinBioTherapeutics (SBTX) Share Price, News & Analysis

→ Secret Bull Market Starts in This Unusual Sector (From Altimetry) (Ad)

Free SBTX Stock Alerts

GBX 9.25

-0.50 (-5.13%)

(As of 04/19/2024 ET)

Compare

Today's Range: 9.06
▼
9.50
50-Day Range: 7
▼
12.75
52-Week Range: 7
▼
29.50

Volume: 58,258 shs
Average Volume: 694,520 shs
Market Capitalization: £17.83 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors

Get SkinBioTherapeutics alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About SkinBioTherapeutics Stock (LON:SBTX)

SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis. The company has an agreement with Croda Plc; and operates two research programmes with the University of Manchester, an oral programme and an inflammation study. It serves cosmetic skincare, food supplements, medical skin care, infection control, and pharmaceutical skincare markets. The company was formerly known as Skinbiotix Ltd and changed its name to SkinBioTherapeutics plc in December 2016. SkinBioTherapeutics plc was incorporated in 2015 and is based in Newcastle upon Tyne, the United Kingdom.

SBTX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SBTX Stock News Headlines

March 26, 2024 | finance.yahoo.com

SkinBioTherapeutics First Half 2024 Earnings: UK£0.008 loss per share (vs UK£0.008 loss in 1H 2023)

March 18, 2024 | lse.co.uk

SkinBioTherapeutics announces research into wound healing bacterium

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

November 17, 2023 | uk.investing.com

SkinBioTherapeutics bags £3m at a modest discount

November 16, 2023 | marketwatch.com

SkinBioTherapeutics to Raise at Least $3.7 Mln

September 14, 2023 | uk.investing.com

Fiverr International Ltd DRC (F2VR34)

September 2, 2023 | uk.investing.com

Societatea de Producere a Energiei Electrice in Hidrocentrale Hidroelectrica SA (ROH2O)

July 11, 2023 | finance.yahoo.com

SBTX.L - SkinBioTherapeutics Plc

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

June 21, 2023 | marketwatch.com

SkinBioTherapeutics Gets Approval for Supplement Launch in Italy

March 30, 2023 | finance.yahoo.com

SkinBioTherapeutics Reports First Half 2023 Earnings

March 28, 2023 | marketwatch.com

SkinBioTherapeutics Shares Fall on Widened 1H Pretax Loss From Higher Costs

March 22, 2023 | finance.yahoo.com

Is SkinBioTherapeutics (LON:SBTX) In A Good Position To Invest In Growth?

December 21, 2022 | marketwatch.com

SkinBioTherapeutics Raises GBP2.6 Mln in Placing, Retail Offer

December 15, 2022 | marketwatch.com

SkinBioTherapeutics to Raise a Minimum of GBP2.5 Mln

October 14, 2022 | finance.yahoo.com

After losing 68% in the past year, SkinBioTherapeutics Plc (LON:SBTX) institutional owners must be relieved by the recent gain

August 31, 2022 | lse.co.uk

SkinBioTherapeutics shares fall as probiotic AxisBiotix-PS sales drop

August 31, 2022 | marketwatch.com

SkinBioTherapeutics Shares Fall After Worse-Than-Expected Supplement Sales

June 15, 2022 | proactiveinvestors.com

SkinBioTherapeutics puzzled by share price, says feedback positive for psoriasis treatment

June 13, 2022 | marketwatch.com

SkinBioTherapeutics Knows No Reason For Share Price Fall

May 20, 2022 | news.yahoo.com

What It's Like Inside a Burning Drift Car

May 20, 2022 | news.yahoo.com

Report raises concerns over lay-offs, cash flow at Cottage clinic; records issues resolved

May 18, 2022 | finance.yahoo.com

We're Keeping An Eye On SkinBioTherapeutics' (LON:SBTX) Cash Burn Rate

March 29, 2022 | lse.co.uk

SkinBioTherapeutics proposes Manprit Singh Randhawa as new CFO

March 29, 2022 | marketwatch.com

SkinBioTherapeutics Shares Drop 30% After Widened 1H Pretax Loss

February 17, 2022 | finance.yahoo.com

What Kind Of Shareholders Hold The Majority In SkinBioTherapeutics Plc's (LON:SBTX) Shares?

January 19, 2022 | marketwatch.com

SkinBioTherapeutics CFO to Step Down

See More Headlines

Receive SBTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SkinBioTherapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/03/2020
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: LON:SBTX
CUSIP: N/A
CIK: N/A
Web: www.skinbiotherapeutics.com
Phone: +44-161-4682760
Fax: N/A
Employees: 11
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.02)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-2,880,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -118.63%
Return on Assets: -61.18%

Debt

Debt-to-Equity Ratio: 2.66
Current Ratio: 6.57
Quick Ratio: 10.01

Sales & Book Value

Annual Sales: £21,949.00
Price / Sales: 812.52
Cash Flow: GBX 1.03 per share
Price / Cash Flow: 9.00
Book Value: GBX 2 per share
Price / Book: 4.63

Miscellaneous

Outstanding Shares: 192,800,000
Free Float: N/A
Market Cap: £17.83 million
Optionable: Not Optionable
Beta: 1.52

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Mr. Stuart John Ashman (Age 58)
CEO & Executive Director
Comp: $371.1k
Mr. Manprit Singh Randhawa (Age 41)
CFO, Secretary & Director
Comp: $261.48k
Laura Bey
Head of Formulations
Ms. Melissa Greenwell
Group Financial Controller

Key Competitors

View All Competitors

SBTX Stock Analysis - Frequently Asked Questions

How have SBTX shares performed in 2024?: SkinBioTherapeutics' stock was trading at GBX 15.25 at the beginning of the year. Since then, SBTX stock has decreased by 39.3% and is now trading at GBX 9.25.
View the best growth stocks for 2024 here.
How were SkinBioTherapeutics' earnings last quarter?: SkinBioTherapeutics plc (LON:SBTX) released its earnings results on Tuesday, March, 3rd. The company reported ($0.64) earnings per share (EPS) for the quarter.
What other stocks do shareholders of SkinBioTherapeutics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other SkinBioTherapeutics investors own include Avacta Group (AVCT), Inspired (INSE), OptiBiotix Health (OPTI), Lb-shell (LBP), Anglo African Oil & Gas (AAOG), Big Sofa Technologies Group (BST), Concepta PLC (CPT.L) (CPT), Fresnillo (FRES) and Shield Therapeutics (STX).
How do I buy shares of SkinBioTherapeutics?: Shares of SBTX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:SBTX) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial